ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Pneumonia
Syndrome

COVID-19 trials near London, England, GBR:

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

The Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS) study is a two-stage, open-label, randomised controlled -...

Enrolling
Covid19
Pneumonia
Drug: Ruxolitinib
Other: Standard of care

Phase 1, Phase 2

Imperial College London
Imperial College London

London, United Kingdom

COVID-19 (SARS-CoV2 virus) was declared a global pandemic by the WHO on 11th March 2020. Currently there are no drugs proven to pre-...

Enrolling
Covid19
Drug: Placebo
Drug: Sotrovimab

Phase 2, Phase 3

NHS Foundation Trust
NHS Foundation Trust

London, United Kingdom and 44 other locations

This study will test the COVID-19 vaccine candidate AZD1222 to investigate its safety, tolerability and capability of boosting immu-...

Active, not recruiting
Covid19
SARS-CoV-2 Infection
Biological: 1x10^10 vp AZD1222
Biological: 5x10^9 vp AZD1222

Phase 1

Imperial College London
Imperial College London

London, United Kingdom

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

London, England, United Kingdom and 76 other locations

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

Phase 2, Phase 3

Novavax
Novavax

London, United Kingdom and 94 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

London, United Kingdom and 90 other locations

An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a SARS-CoV-2 Omicron Challenge Strain (BA.5) in Healthy Participants 18 to 40...

Enrolling
SARS-CoV-2 Infection
Biological: SARS-CoV-2 omicron virus dose arm 2
Biological: SARS-CoV-2 omicron virus dose arm 3

Early Phase 1

Hvivo

London, United Kingdom

The study GPPAD-05 AVAnT1A is a phase 4 clinical trial intending to enroll 2252 children, who will be randomly assigned to receive COVID-19...

Enrolling
Diabetes Mellitus, Type 1
Drug: Sodium Chloride 0.9% Inj
Drug: Comirnaty Injectable Product

Phase 4

Technical University of Munich

Cambridge, United Kingdom and 7 other locations

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Active, not recruiting
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

London, United Kingdom and 35 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

London, United Kingdom and 246 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems